Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II–receptor blockers (ARBs) can influence atrial remodeling, and some clinical studies suggest that they may prevent atrial fibrillation. Treatment with valsartan was not associated with a reduction in the incidence of recurrent atrial fibrillation.

Related Articles

Atrial Fibrillatory Wall Motion and Degree of Atrial Remodeling in Patients with Atrial Fibrillation: A Tissue Velocity Imaging Study
Journal of Cardiovascular Electrophysiology, 10/28/09    Relevance Score: 70%

Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrillation
American Family Physician, 11/12/09    Relevance Score: 69%

Sudden atrial fibrillation associated with acute alcohol ingestion and cor triatriatum
Baylor UMC Proceedings, 10/27/09    Relevance Score: 69%

Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation
Evidence-Based Medicine, 10/26/09    Relevance Score: 69%

Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter
Archives of Internal Medicine, 10/14/09    Relevance Score: 69%

Today in Clinical Pharmacology...keeping you current

Doxorubicin Cardiomyopathy
Cardiology, 12/11/09

Valsartan plus hydrochlorothiazide for first-line therapy in hypertension
Expert Review of Cardiovascular Therapy , 12/11/09

Perioperative Intravenous Amiodarone Does Not Reduce the Burden of Atrial Fibrillation in Patients Undergoing Cardiac Valvular Surgery
Anesthesiology, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address